Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study on the Effectiveness of Clindamycin and Tretinoin Gel for Treating Acne in Patients
GreeceStudy on Dupilumab for Itch Relief in Adults with Lichen Simplex Chronicus (Neurodermatitis)
BelgiumStudy of Deucrictibant Extended-Release Tablets for Prevention of Hereditary Angioedema Attacks in Adults and Adolescents
BulgariaStudy on the Use of Indocyanine Green and Technetium (99mTc) Nanocolloid for Sentinel Node Biopsy in Patients with Melanoma, Oral Cancer, or Penile Cancer
The NetherlandsStudy on the Effectiveness of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced Melanoma
SpainStudy on the Effectiveness and Safety of Brensocatib for Adults with Moderate to Severe Hidradenitis Suppurativa
BulgariaStudy on the Effectiveness of IC0624 for Patients with Mild to Moderate Hidradenitis Suppurativa
GermanyStudy of BI-1607, Ipilimumab, and Pembrolizumab for Patients with Advanced Melanoma
GermanyStudy on the Safety of INF904 for Patients with Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa
BulgariaStudy on the Effects of Deucravacitinib for Patients with Moderate to Severe Plaque Psoriasis
GermanyStudy on Long-Term Safety of Briquilimab for Patients with Chronic Urticaria
GermanyStudy on the Effectiveness of AVTX-009 for Treating Moderate to Severe Hidradenitis Suppurativa in Patients
BulgariaThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
